Who is sponsoring NCT03293446?

NCT03293446 is sponsored by Erasmus Medical Center.

What drugs are being tested in NCT03293446?

Interventions in NCT03293446: Urinary acidification test.

What condition does NCT03293446 study?

NCT03293446 studies Chronic Kidney Disease stage4.

Is NCT03293446 still recruiting?

NCT03293446 is currently completed. Last updated 20 June 2019.

Last reviewed 2019-06-20 · How we verify

NCT03293446: AC/DC

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

AC/DC Study: Acidification Test in Patients With Chronic Kidney Disease and Healthy Controls

Completed NA Last updated 20 June 2019

What this trial tests

NA trial testing Urinary acidification test in Chronic Kidney Disease stage4 in 29 participants. Completed in 11 November 2018.

Timeline

7 October 2016

Primary endpoint
11 November 2018

11 November 2018

Quick facts

Lead sponsor	Erasmus Medical Center
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	basic science
Enrollment	29
Start date	7 October 2016
Primary completion	11 November 2018
Estimated completion	11 November 2018
Sites	1 location across Netherlands

Drugs / interventions tested

Urinary acidification test

Conditions studied

Chronic Kidney Disease stage4 — all drugs for Chronic Kidney Disease stage4 →

Sponsor

Erasmus Medical Center

Who can join

Adults 18 to 99, male only, with Chronic Kidney Disease stage4. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this study the effect of an acute acid load on the intrarenal renin angiotensin-system is evaluated in patients with chronic kidney disease and healthy controls

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Acute acid load in chronic kidney disease increases plasma potassium, plasma aldosterone and urinary renin.
Bovée DM, Janssen JW, Zietse R, J Danser AH, et al · · 2020 · cited 2× · PMID 32710099 · DOI 10.1093/ndt/gfaa136

Verify or expand the search:

Other recruiting trials for Chronic Kidney Disease stage4

Currently open trials in the same condition.

NCT07309094 — Clinical, Morphometric and Biochemical Effects on Adiposopathy Associated With the Use of GLP-1RA in CKD · recruiting

Other Erasmus Medical Center trials

Trials by the same sponsor.

NCT07406269 — Clinical Evaluation of AI Decision Support for Early Rehabilitation After Surgery · NA · not yet recruiting
NCT07402109 — CBCT Guided Markerless SBRT for Renal Cell Cancer · NA · recruiting
NCT07383194 — Prediction Models for LDLT Outcomes · not yet recruiting
NCT07426575 — Evaluating the Usability of New Dialysis Bags · not yet recruiting
NCT07329296 — The Regenerative Capacity of the Donor Liver After Living Donor Liver Transplantation: an Ambidirectional Cohort Study · enrolling by invitation

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03293446 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Erasmus Medical Center
Last refreshed: 20 June 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03293446.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing